PCOS Is Now PMOS: Why the Name Change Matters for Women’s Health

In May 2026, a landmark international consensus officially renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) — a change more than a decade in the making. The new name isn’t simply a rebranding exercise. It’s a recognition that this common condition has never been just about the ovaries.

For millions of women, this shift represents something much bigger: validation. It acknowledges what researchers and clinicians have increasingly recognized over the past two decades — this is a complex, whole-body condition involving hormonal regulation, metabolism, inflammation, reproductive health, and long-term cardiometabolic risk.

More Than “Cysts on the Ovaries”

The term Polycystic Ovary Syndrome has long been considered a misleading name. Many women diagnosed with the condition don’t actually have ovarian cysts — what providers see on ultrasound are multiple immature follicles, not true cysts. The original name focused attention almost exclusively on the ovaries, when the condition affects nearly every major hormone system in the body.

The new name — Polyendocrine Metabolic Ovarian Syndrome (PMOS) — better reflects what is actually happening:

How Common Is PMOS?

Symptoms often begin during adolescence, but many women spend years seeking answers before receiving a diagnosis. Because PMOS can present differently from one woman to another, diagnosis should be based on a comprehensive clinical evaluation rather than any single symptom, laboratory result, or ultrasound finding.

PMOS Is Much More Than Irregular Periods

While irregular menstrual cycles remain one of the hallmark features, PMOS can affect nearly every aspect of health. Women may experience:

Underneath the surface, many women are also dealing with insulin resistance, chronic low-grade inflammation, hyperandrogenism, blood sugar dysregulation, increased cardiovascular risk, and greater risk of Type 2 diabetes.

Why Functional Medicine Has Been Talking About This for Years

Long before the name changed, functional medicine recognized that PCOS was never simply an ovarian disorder. Instead of asking “How do we regulate your menstrual cycle?” — functional medicine asks “Why are your hormones becoming dysregulated in the first place?”

Insulin Resistance

Insulin resistance is one of the strongest drivers of PMOS. Elevated insulin levels stimulate the ovaries to produce more androgens, contributing to acne, unwanted hair growth, irregular ovulation, and weight gain. Improving insulin sensitivity often improves many other symptoms simultaneously.

Chronic Inflammation

Inflammation can worsen insulin resistance while also affecting hormone signaling throughout the body. Reducing inflammatory burden through nutrition, sleep, stress reduction, and lifestyle changes often becomes an important piece of treatment.

Stress and Cortisol

Chronic stress doesn’t cause PMOS by itself, but elevated cortisol can worsen insulin resistance, sleep quality, inflammation, appetite regulation, and reproductive hormones.

Gut Health

Emerging research suggests the gut microbiome may influence inflammation, insulin sensitivity, and hormone metabolism. Optimizing gut health has become an area of interest within functional medicine as part of a comprehensive approach to care.

What Does Functional Medicine Treatment Look Like?

Rather than focusing solely on symptom suppression, functional medicine typically emphasizes identifying and addressing the underlying drivers. A comprehensive plan may include:

A New Name, But an Even Bigger Opportunity

Changing the name from PCOS to PMOS won’t immediately change treatment guidelines. But it represents an important cultural and medical shift. When terminology better reflects biology, it can change how clinicians think about a condition, how researchers study it, and how patients understand what they’re experiencing.

By recognizing PMOS as a complex endocrine and metabolic condition — not simply a reproductive disorder — we move closer to earlier diagnosis, more personalized care, better research, and improved long-term health for millions of women.

Written By Shelley Junkin Chief Operating Officer, MyPracticeConnect® Shelley oversees operations and clinical content at MyPracticeConnect, supporting providers nationwide in implementing functional medicine into their practices.